Vistas y estadísticas descargadas: Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
Mapa geográfico
| Región | Cantidad |
|---|---|
| NA - América del Norte | 28 |
| EU - Europa | 12 |
| AS - Asia, otros | 6 |
| Desconocido | 1 |
| Total | 47 |
| País | Cantidad |
|---|---|
| US - Estados Unidos de América | 25 |
| FR - Francia | 10 |
| CA - Canadá | 3 |
| HK - Hong Kong | 2 |
| SG - Singapur | 2 |
| CH - Suiza | 1 |
| CN - China | 1 |
| GB - Reino Unido | 1 |
| JP - Japón | 1 |
| Desconocido | 1 |
| Total | 47 |
| Ciudad | Cantidad |
|---|---|
| Strasbourg | 10 |
| Vancouver | 3 |
| Ashburn | 2 |
| Baltimore | 2 |
| Boardman | 1 |
| Central | 1 |
| Columbus | 1 |
| Hong Kong | 1 |
| Montagny | 1 |
| Phoenix | 1 |
| other | 24 |
| Total | 47 |
| Nombre del archivo | Cantidad |
|---|---|
| 179371 - Economic_analysis_insulin_glargine.pdf - ITEM:( 10553/77015) | 47 |
| Total | 47 |
| Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 0 | 1 | 0 | 0 | 0 | 11 | 0 | 1 | 0 | 0 | 0 | 0 | 13 |
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| 2023 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 4 |
| 2024 | 0 | 3 | 2 | 0 | 5 | 3 | 4 | 1 | 1 | 1 | 2 | 2 | 24 |
| 2025 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| TOTAL | 47 | ||||||||||||